“Increasing Use of Bioactive and Resorbable Materials”
- One prominent trend in the global bone void filler market is the increasing use of bioactive and resorbable materials
- These advanced fillers promote better bone regeneration by actively interacting with the surrounding bone tissue, enhancing healing and integration
- For instance, In March 2025, Elute, Inc. received U.S. Food and Drug Administration (FDA) approval for BonVie+, a novel synthetic resorbable bone void filler implant. BonVie+ is designed to fill bone defects and is gradually replaced by new bone over time, promoting natural healing
- Resorbable materials, on the other hand, gradually degrade over time, eliminating the need for secondary surgeries to remove the filler, making them more appealing for both patients and surgeons
- This trend is improving patient outcomes by providing more effective, longer-lasting treatments, reducing recovery times, and lowering the risk of adverse reactions, which is fueling the growth of the bone void filler market
Frequently Asked Questions
Asia-Pacific is the fastest growing region in the global bone void filler market driven by increasing healthcare investments, a rapidly aging population, and a rising prevalence of orthopedic disorders such as osteoporosis and fractures.
The increasing use of bioactive and resorbable materials, is emerging as a pivotal trend driving the global bone void filler market.
The major factors driving the growth of the bone void filler market are increasing number of orthopedic surgeries and bone-related disorders and advancements in biomaterial technologies.
The primary challenges include high cost of bone void fillers and regulatory and approval delays.
The orthopedic surgery segment is expected to dominate the global bone void filler market holding a major market share in 2025, driven by the increasing prevalence of bone fractures, trauma cases, and degenerative bone diseases.
